Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
RHINO BIOTECH Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
QIAGEN | 38,305 | -0,23 % | QIAGEN N.V.: QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio | Full portfolio of QIAstat-Dx panels now CE-IVDR certified for use in clinical syndromic testing, underscoring commitment to highest-quality diagnostics CE-IVDR clearance granted for QIAstat-Dx... ► Artikel lesen | |
EVOTEC | 6,150 | +3,40 % | Evotec Aktie: Ein Schimmer der Hoffnung | Entspannung bei der Evotec Aktie? Die Biotech-Aktie war in den vergangenen Wochen wieder einmal gefallen, hat in den letzten Tagen aber im Bereich 5,70/5,78 Euro sichtlich charttechnische Unterstützung... ► Artikel lesen | |
SUMMIT THERAPEUTICS | 18,120 | -4,33 % | Summit Therapeutics stock rating reiterated at Buy by H.C. Wainwright | ||
BIONTECH | 84,00 | +0,90 % | BioNTech Aktie: Ist das der Startschuss für den Krebs-Killer aus Mainz? | © Foto: Foto von FRANK MERIÑO auf PexelsDas Warten hat endlich ein Ende. BioNTech schreibt mit seinem Krebsmedikament BNT323 Medizingeschichte.Nach jahrelanger Forschung meldet das Mainzer Unternehmen... ► Artikel lesen | |
AVIDITY BIOSCIENCES | 41,440 | +3,11 % | Avidity Biosciences schließt Kapitalerhöhung über 690 Millionen US-Dollar ab | ||
CG ONCOLOGY | 35,760 | +3,35 % | Hedge Fund and Insider Trading News: Ray Dalio, Warren Buffett, Bill Ackman, Dan Loeb, Arrowpoint Investment Partners, CG Oncology Inc (CGON), Tesla Inc (TSLA), and More | ||
RAPPORT THERAPEUTICS | 26,190 | +5,90 % | Truist Securities initiates Rapport Therapeutics stock with Buy rating | ||
BEAM THERAPEUTICS | 22,910 | +7,66 % | Fortschritte in der Pipeline: H.C. Wainwright bestätigt "Buy"-Rating für Beam Therapeutics | ||
Y-MABS THERAPEUTICS | 8,610 | 0,00 % | Y-mAbs Therapeutics, Inc. - 8-K, Current Report | ||
MINERALYS THERAPEUTICS | 37,420 | +3,34 % | Hedge Fund and Insider Trading News: Louis Bacon, Bill Ackman, Warren Buffett, Dan Loeb, Silver Point Capital, Starboard Value, Elliott Management, Mineralys Therapeutics Inc (MLYS), DuPont de Nemours Inc (DD), and More | ||
RECURSION PHARMACEUTICALS | 4,835 | +1,26 % | What Analysts Are Saying About Recursion Pharmaceuticals Stock | ||
MOONLAKE IMMUNOTHERAPEUTICS | 53,30 | +0,17 % | MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update | Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 and an expected submission of a Biologic License Application (BLA) in the... ► Artikel lesen | |
KYMERA THERAPEUTICS | 48,750 | +3,15 % | Kymera initiated at Outperform on potential of lead skin drug | ||
ADMA BIOLOGICS | 15,695 | +2,55 % | ADMA Biologics, Inc.: ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update | 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted... ► Artikel lesen | |
ARS PHARMACEUTICALS | 9,410 | -5,43 % | ARS Pharmaceuticals, Inc.: EURneffy (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) | EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights to... ► Artikel lesen |